[Federal Register Volume 84, Number 29 (Tuesday, February 12, 2019)]
[Notices]
[Pages 3455-3456]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2019-01958]
-----------------------------------------------------------------------
DEPARTMENT OF HEALTH AND HUMAN SERVICES
Centers for Disease Control and Prevention
[Docket No. CDC-2019-0002]
Advisory Committee on Immunization Practices (ACIP); Correction
AGENCY: Centers for Disease Control and Prevention (CDC), Department of
Health and Human Services (HHS).
ACTION: Notice of meeting with comment period; correction.
-----------------------------------------------------------------------
SUMMARY: On January 28, 2019, the Centers for Disease Control and
Prevention (CDC) in the Department of Health and Human Services (HHS)
published a notice announcing the next meeting of the Advisory
Committee on Immunization Practices on February 27-28, 2019 in Atlanta,
GA. The notice did not include the docket number for public comment or
instructions for submitting public comment. This notice provides that
information for the public.
DATES: The meeting will be held on February 27-28, 2019 at the CDC Tom
Harkin Global Communication Center, Centers for Disease Control and
[[Page 3456]]
Prevention Headquarters (Building 19), Room 232, 1600 Clifton Road NE,
Atlanta, GA 30329. Written comments must be received on or before March
2, 2019.
ADDRESSES: You may submit comments, identified by Docket No. CDC-2019-
0002 by any of the following methods:
Federal eRulemaking Portal: http://www.regulations.gov.
Follow the instructions for submitting comments.
Mail: Centers for Disease Control and Prevention, 1600
Clifton Rd. NE, Mailstop A-27, Atlanta, GA 30329-4027.
Instructions: All submissions received must include the agency name
and Docket Number.
Instructions: All relevant comments received will be posted without
change to http://regulations.gov, including any personal information
provided. For access to the docket to read background documents or
comments received, go to http://www.regulations.gov.
FOR FURTHER INFORMATION CONTACT: Stephanie Thomas, ACIP Committee
Management Specialist, National Center for Immunization and Respiratory
Diseases, Centers for Disease Control and Prevention, telephone 404-
639-8836, email [email protected].
SUPPLEMENTARY INFORMATION: In accordance with the Federal Advisory
Committee Act, the Centers for Disease Control and Prevention (CDC),
announces the following meeting of the Advisory Committee on
Immunization Practices (ACIP). This meeting is open to the public,
limited only by room seating. The meeting room accommodates 216 for
public seating. Rooms 245, 246, and 247, adjacent to the meeting room,
will be available once the meeting room reaches capacity, providing up
to 120 additional seats. Time will be available for public comment. The
meeting will be webcast live via the World Wide Web; for instructions
and more information on ACIP please visit the ACIP website: http://www.cdc.gov/vaccines/acip/index.html. Written public comments submitted
by 72 hours prior to the ACIP meeting will be provided to the ACIP
members before the meeting.
Public Participation
Interested persons or organizations are invited to participate by
submitting written views, recommendations, and data. Please note that
comments received, including attachments and other supporting
materials, are part of the public record and are subject to public
disclosure. Comments will be posted on https://www.regulations.gov.
Therefore, do not include any information in your comment or supporting
materials that you consider confidential or inappropriate for public
disclosure. If you include your name, contact information, or other
information that identifies you in the body of your comments, that
information will be on public display. CDC will review all submissions
and may choose to redact, or withhold, submissions containing private
or proprietary information such as Social Security numbers, medical
information, inappropriate language, or duplicate/near duplicate
examples of a mass-mail campaign. CDC will carefully review and
consider all comments submitted to the docket.
Matters To Be Considered
The agenda will include discussions on human papillomavirus
vaccines, pneumococcal vaccines, Japanese encephalitis vaccines,
influenza vaccines, anthrax vaccine, hepatitis vaccines, Pertussis
vaccine, herpes zoster vaccine, and meningococcal vaccines. A
recommendation vote is scheduled for anthrax vaccine and Japanese
encephalitis vaccines. Agenda items are subject to change as priorities
dictate. For more information on the meeting agenda visit https://www.cdc.gov/vaccines/acip/meetings/meetings-info.html.
The Chief Operating Officer, Centers for Disease Control and
Prevention, has been delegated the authority to sign Federal Register
notices pertaining to announcements of meetings and other committee
management activities, for both the Centers for Disease Control and
Prevention and the Agency for Toxic Substances and Disease Registry.
Dated: January 30, 2019.
Sherri Berger,
Chief Operating Officer, Centers for Disease Control and Prevention.
[FR Doc. 2019-01958 Filed 2-11-19; 8:45 am]
BILLING CODE 4163-18-P